NYSE Euronext Announces Trading Volumes for October 2009

November 6, 2009 2:33 AM EST

October Trading Volumes Mostly Lower Versus Record Prior Year Levels;

U.S. Options Market Share Increases to 22.8%; Third Consecutive Monthly Increase in European Cash Trading Volumes

NEW YORK--(BUSINESS WIRE)-- NYSE Euronext (NYX) today announced trading volumes for its global cash equities and derivatives exchanges for October 20091. Trading volumes in October 2009 were mostly lower compared to October 2008 levels, during which crisis-level volatility drove record trading volumes. Trading volumes compared to September 2009 were mixed, with U.S. options and European cash increasing 6.3% and 7.1%, respectively, and European derivatives and U.S. cash decreasing, 11.1% and 3.3%, respectively.

Highlights

    --  NYSE Euronext European derivatives products average daily volume ("ADV")
        in October 2009 of 3.9 million contracts decreased 12.9% compared to
        October 2008, and decreased 11.1% from September 2009. Total interest
        rate products ADV in October 2009 of 2.0 million contracts decreased
        9.5% compared to October 2008 and total equity products ADV of 1.8
        million contracts decreased 16.9% compared to October 2008.
    --  NYSE Euronext U.S. equity options ADV of 3.2 million contracts in
        October 2009 increased 23.3% compared to October 2008 levels, and
        increased 6.3% from September 2009. NYSE Euronext's U.S. options
        exchanges accounted for 22.8% of the total consolidated equity options
        trading in October 2009, up from 17.6% in October 2008, and up from
        21.4% in September 2009.
    --  NYSE Liffe U.S. futures and futures options ADV in October 2009 of
        approximately 22,000 contracts increased from approximately 21,000
        contracts in September 2009 with the launch of equity index futures
        trading in September 2009 based on the MSCI U.S., EM and EAFE indexes.
    --  NYSE Euronext European cash products ADV of 1.6 million transactions in
        October 2009 decreased 26.1% compared to October 2008, but increased
        7.1% from September 2009 and represented the third consecutive monthly
        increase in trading volumes since July with market share stable at
        approximately 78%.
    --  NYSE, NYSE Arca and NYSE Amex ("NYSE Group") U.S. cash products handled
        ADV of 2.9 billion shares in October 2009 decreased 38.9% compared to
        October 2008 and decreased 3.3% compared to September 2009. NYSE Group
        matched share of all U.S. equity trading volume in October 2009 was
        28.1%, up from 28.0% in September 2009, and compared to matched market
        share of 24.7% for our next largest competitor. NYSE Group's Tape A
        matched market share in October 2009 was 36.6%, up from 36.1% in
        September 2009.
    --  NYSE Euronext is the largest exchange operator in the two fastest
        growing tapes in the U.S. equity markets. Year-to-date, total Tape A and
        Tape B consolidated ADV of 7.9 billion shares increased a combined
        23.6%, compared to the prior year period, while Tape C consolidated ADV
        of 2.3 billion shares has declined 0.9% during the same period.

Derivatives Trading

European Derivatives

    --  NYSE Euronext European derivatives products ADV in October 2009 was 3.9
        million futures and options contracts, a decrease of 12.9% from October
        2008, and a decrease of 11.1% from the 4.4 million contracts recorded in
        September 2009. The 3.9 million in futures and options contracts ADV in
        October 2009 consisted of 3.3 million contracts executed through our
        full-service LIFFE CONNECT trading platform and 0.6 million, or 15.6%,
        executed through Bclear, NYSE Liffe's trade administration and clearing
        service for OTC products. Year-to-date European derivatives products ADV
        of 4.1 million contracts was 3.3% below prior year levels.
    --  Total interest rate products ADV of 2.0 million contracts in October
        2009 decreased 9.5% and 12.7% from October 2008 and September 2009,
        respectively. Year-to-date, total interest rate products ADV decreased
        12.4% compared to the prior year period.
    --  Total equity products (including Bclear) ADV of 1.8 million contracts in
        October 2009 decreased 16.9% compared to October 2008, and decreased
        9.7% compared to September 2009. Year-to-date total equity products ADV
        increased 7.9% from the prior year period driven primarily by a 37.0%
        increase in volume executed through Bclear.

U.S. Derivatives

    --  NYSE Group U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.2
        million contracts in October 2009 increased 23.3% compared to October
        2008 and increased 6.3% compared to September 2009. The increase in ADV
        year-over-year and compared to September 2009 was driven in part by
        increased trading related to the anticipated sale of an equity stake in
        NYSE Amex Options and NYSE Amex Options pricing changes implemented July
        1, 2009.
    --  Year-to-date, NYSE Group U.S. equity options volume of 2.6 million
        contracts was 47.5% above the prior year period driven in part by the
        addition of the former Amex options business.
    --  Total U.S. consolidated options ADV decreased 4.8% to 13.9 million
        contracts in October 2009, and was flat compared to September 2009.
        Year-to-date, U.S. consolidated options ADV of 13.6 million contracts
        was 0.7% above the prior year period.
    --  NYSE Euronext's U.S. options exchanges accounted for 22.8% of the total
        consolidated equity options trading in October 2009, up from 17.6% in
        October 2008, and up from 21.4% in September 2009. The increase in
        market share year-over-year and compared to September was driven in part
        by increased trading related to the anticipated sale of an equity stake
        in NYSE Amex Options and NYSE Amex Options pricing changes implemented
        July 1, 2009.
    --  NYSE Euronext U.S. futures and futures options (NYSE Liffe U.S.) ADV in
        October 2009 of approximately 22,000 contracts increased from
        approximately 21,000 contracts in September 2009 with the launch of
        equity index futures trading in September based on the MSCI U.S., EM and
        EAFE indexes.

Cash Trading

European Cash

    --  NYSE Euronext European cash products ADV of 1.6 million transactions in
        October 2009 decreased 26.1%, compared to October 2008, but increased
        7.1% compared to September 2009 and represented the third consecutive
        monthly increase in ADV since July with market share stable at
        approximately 78%. Year-to-date, European cash products ADV of 1.4
        million transactions was 12.0% below the same period last year.

U.S. Cash

    --  NYSE Group U.S. cash products handled ADV in October 2009 decreased
        38.9% to 2.9 billion shares, compared to October 2008, and decreased
        3.3% from September 2009. Year-to-date, NYSE Group handled ADV of 3.5
        billion shares was 1.3% below the same period last year.
    --  NYSE Group matched share of all U.S. equity volume in October 2009 was
        28.1%, compared to matched market share of 24.7% for our next largest
        competitor.
    --  Consolidated Tape A and Tape B trading volume in October 2009 accounted
        for approximately 75% of all Consolidated Tape trading in the U.S.
        market which includes trade reporting facility ("TRF") volumes.

NYSE-listed (Tape A)

    --  NYSE Group's Tape A matched market share in October 2009 was 36.6%, up
        from 36.1% in September 2009, and compared to matched market share of
        19.5% for our next largest competitor. Tape A matched market share for
        NYSE was 25.1% in October 2009, above the 24.5% market share reported in
        October 2008. TRF market share across Tape A was 33.2%, down from 37.6%
        in August 2009, but up from 25.0% in December 2008.
    --  Designated Market Maker ("DMM") participation in October 2009 was 9.3%,
        compared to 9.1% in September 2009. Supplemental Liquidity Provider
        ("SLP") participation in October 2009 was 10.3%, compared to 9.5% in
        September 2009. A total of 7 SLPs are now on the platform. DMM and SLP
        participation pertain only to trading on NYSE.

NYSE Arca and NYSE Amex-listed (Tape B)

    --  Tape B matched market share of NYSE Group in October 2009 was 22.5%,
        down from 22.6% in September 2009, compared to matched market share of
        27.3% for our nearest competitor. TRF market share across Tape B in
        October 2009 was 32.6% compared to 21.5% in December 2008.

Nasdaq-listed (Tape C)

    --  NYSE Group's Tape C matched market share in October 2009 increased to
        12.3% from 12.2% in September 2009, compared to matched market share of
        34.6% for our nearest competitor. TRF market share across Tape C in
        October 2009 was 38.9% compared to 29.9% in December 2008.

Exchange Traded Products

    --  NYSE Group matched exchange-traded products ADV (included in volumes
        from Tape B and Tape C noted above) of 346 million shares in October
        2009 decreased 54.3% compared to October 2008, but increased 9.1%
        compared to September 2009. Year-to-date, matched exchange-traded
        products ADV was 11.5% above the prior year period.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With more than 8,000 listed issues, NYSE Euronext's equities markets -- the New York Stock Exchange, Euronext, NYSE Arca and NYSE Amex -- represent nearly 40 percent of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, the leading European derivatives business and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the S&P 100 index and Fortune 500. For more information, please visit: www.nyx.com

Cautionary Note Regarding Forward-Looking Statements

This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext's results to differ materially from current expectations include, but are not limited to: NYSE Euronext's ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext's reference document for 2008 ("document de reference") filed with the French Autorite des Marches Financiers (Registered on April 28, 2009 under No. R. 09-031), 2008 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorite des Marches Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.

1 Euronext equities transactions count each buy and sell order as separate transactions, NYSE Group equities transactions count buy and sell orders together as a single transaction. All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction.

NYSE Euronext

Monthly Volume Summary - Cash Products

                  Average Daily Volume       Total Volume                   Average Daily     Total Volume
                                                                            Volume

                                                                                     % Chg                 % Chg
                                                                            YTD      vs.                   vs.
(Unaudited)       Oct-09   Oct-08   % Chg    Oct-09     Oct-08     % Chg    2009              YTD 2009
                                                                                     YTD                   YTD
                                                                                     2008                  2008

Number of
Trading Days -    22       23                22         23                  213               213
European
Markets

Number of
Trading Days -    22       23                22         23                  210               210
U.S. Markets

European Cash
Products          1,580    2,138    -26.1 %  34,758     49,173     -29.3 %  1,402    -12.0 %  298,617      -12.8 %
(trades in
thousands)

Equities          1,516    2,070    -26.8 %  33,358     47,617     -29.9 %  1,343    -12.8 %  285,994      -13.6 %

Exchange-Traded   17       16       4.8   %  378        377        0.3   %  14       65.6  %  3,072        64.0  %
Funds

Structured        40       46       -12.4 %  883        1,054      -16.2 %  39       -1.4  %  8,342        -2.3  %
Products

Bonds             6        5        16.1  %  139        126        11.0  %  6        8.4   %  1,209        7.4   %

U.S. Cash
Products          2,922    4,783    -38.9 %  64,279     110,019    -41.6 %  3,460    -1.3  %  726,563      -2.2  %
(shares in
millions)2

NYSE Listed
(Tape A)
Issues1

NYSE Group
Handled Volume    2,147    3,364    -36.2 %  47,238     77,383     -39.0 %  2,525    -2.1  %  530,154      -3.0  %
2

NYSE Group
Matched Volume    1,972    3,023    -34.8 %  43,389     69,535     -37.6 %  2,293    -1.4  %  481,508      -2.3  %
3

Total NYSE
Listed            5,388    7,052    -23.6 %  118,535    162,186    -26.9 %  5,932    17.8  %  1,245,760    16.7  %
Consolidated
Volume

NYSE Group
Share of Total
Consolidated
Volume

Handled Volume    39.9  %  47.7  %  -7.8  %  39.9    %  47.7    %  -7.8  %  42.6  %  -8.6  %  42.6      %  -8.6  %
2

Matched Volume    36.6  %  42.9  %  -6.3  %  36.6    %  42.9    %  -6.3  %  38.7  %  -7.5  %  38.7      %  -7.5  %
3

NYSE Arca &
Amex (Tape B)
Listed Issues

NYSE Group
Handled Volume    418      844      -50.5 %  9,189      19,421     -52.7 %  549      19.7  %  115,284      18.5  %
2

NYSE Group
Matched Volume    365      726      -49.7 %  8,034      16,707     -51.9 %  480      20.6  %  100,818      19.5  %
3

Total NYSE Arca
& Amex Listed     1,625    2,399    -32.3 %  35,741     55,170     -35.2 %  1,999    44.7  %  419,824      43.3  %
Consolidated
Volume

NYSE Group
Share of Total
Consolidated
Volume

Handled Volume    25.7  %  35.2  %  -9.5  %  25.7    %  35.2    %  -9.5  %  27.5  %  -5.7  %  27.5      %  -5.7  %
2

Matched Volume    22.5  %  30.3  %  -7.8  %  22.5    %  30.3    %  -7.8  %  24.0  %  -4.8  %  24.0      %  -4.8  %
3

Nasdaq Listed
(Tape C) Issues

NYSE Group
Handled Volume    357      575      -37.9 %  7,852      13,215     -40.6 %  386      -17.2 %  81,125       -18.0 %
2

NYSE Group
Matched Volume    288      485      -40.6 %  6,339      11,164     -43.2 %  315      -19.5 %  66,171       -20.2 %
3

Total Nasdaq
Listed            2,335    2,796    -16.5 %  51,363     64,302     -20.1 %  2,302    -0.9  %  483,508      -1.8  %
Consolidated
Volume

NYSE Group
Share of Total
Consolidated
Volume

Handled Volume    15.3  %  20.6  %  -5.3  %  15.3    %  20.6    %  -5.3  %  16.8  %  -3.3  %  16.8      %  -3.3  %
2

Matched Volume    12.3  %  17.4  %  -5.1  %  12.3    %  17.4    %  -5.1  %  13.7  %  -3.1  %  13.7      %  -3.1  %
3

Exchange-Traded
Funds1,4

NYSE Group
Handled Volume    395      872      -54.7 %  8,697      20,056     -56.6 %  539      11.1  %  113,193      10.1  %
2

NYSE Group
Matched Volume    346      758      -54.3 %  7,623      17,426     -56.3 %  473      11.5  %  99,244       10.5  %
3

Total ETF
Consolidated      1,592    2,602    -38.8 %  35,029     59,844     -41.5 %  2,018    38.0  %  423,877      36.7  %
Volume

NYSE Group
Share of Total
Consolidated
Volume

Handled Volume    24.8  %  33.5  %  -8.7  %  24.8    %  33.5    %  -8.7  %  26.7  %  -6.5  %  26.7      %  -6.5  %
2

Matched Volume    21.8  %  29.1  %  -7.3  %  21.8    %  29.1    %  -7.3  %  23.4  %  -5.6  %  23.4      %  -5.6  %
3

NYSE Euronext

Monthly Volume Summary - Derivatives Products

              Average Daily Volume         Total Volume                   Average Daily      Total Volume
                                                                          Volume

                                                                                    % Chg                 % Chg
(Unaudited;                                                                         vs.                   vs.
contracts in  Oct-09    Oct-08    % Chg    Oct-09     Oct-08     % Chg    YTD 2009           YTD 2009
thousands)                                                                          YTD                   YTD
                                                                                    2008                  2008

Number of
Trading Days  22        23                 22         23                  213                213
- European
Markets

Number of
Trading Days  22        23                 22         23                  210                210
- U.S.
Markets

European
Derivatives   3,871     4,447     -12.9 %  85,173     102,270    -16.7 %  4,119     -3.3  %  877,282      -4.2  %
Products

 of which     604       664       -9.1  %  13,285     15,276     -13.0 %  1,023     37.0  %  217,849      35.7  %
 Bclear

Total
Interest      1,992     2,201     -9.5  %  43,824     50,612     -13.4 %  2,014     -12.4 %  428,949      -13.2 %
Rate
Products

 Short Term
 Interest     1,881     2,107     -10.7 %  41,376     48,455     -14.6 %  1,914     -12.8 %  407,587      -13.6 %
 Rate
 Products

 Medium and
 Long Term
 Interest     111       94        18.7  %  2,448      2,157      13.5  %  100       -4.3  %  21,361       -5.2  %
 Rate
 Products5

Total Credit
Derivatives   -         -                  -          -                   -                  -
Products
(Bclear)

Total Equity  1,824     2,195     -16.9 %  40,118     50,485     -20.5 %  2,057     7.9   %  438,115      6.9   %
Products6

 Individual
 Equity       1,197     1,253     -4.5  %  26,332     28,829     -8.7  %  1,439     17.5  %  306,462      16.4  %
 Products

 Equity
 Index        627       942       -33.4 %  13,786     21,656     -36.3 %  618       -9.4  %  131,653      -10.3 %
 Products

 of which     604       664       -9.1  %  13,285     15,276     -13.0 %  1,023     37.0  %  217,849      35.7  %
 Bclear

 Individual
 Equity       475       503       -5.5  %  10,461     11,570     -9.6  %  891       40.4  %  189,841      39.1  %
 Products

 Equity
 Index        128       161       -20.3 %  2,824      3,706      -23.8 %  131       17.6  %  28,008       16.5  %
 Products

Commodity     56        51        9.7   %  1,230      1,172      4.9   %  48        -11.0 %  10,218       -11.8 %
Products

 of which     -         -                  -          -                   -                  -
 Bclear

U.S.
Derivatives
Products

Equity
Options7

NYSE Group
Options       3,185     2,584     23.3  %  70,074     59,429     17.9  %  2,559     47.5  %  537,482      46.1  %
Contracts

Total
Consolidated  13,942    14,644    -4.8  %  306,729    336,805    -8.9  %  13,573    0.7   %  2,850,277    -0.3  %
Options
Contracts

NYSE Group
Share of      22.8   %  17.6   %           22.8    %  17.6    %           18.9   %  6.0   %  18.9      %  5.3   %
Total

NYSE Liffe
U.S.

Futures and
Futures       22.1      -                  485.2      -                   17.1      -        3,598.6      -
Options
Volume

1  Includes all volume executed in NYSE Group crossing sessions.

   Represents the total number of shares of equity securities and ETFs
2  internally matched on the NYSE Group's exchanges or routed to and executed at
   an external market center. NYSE Arca routing includes odd-lots.

3  Represents the total number of shares of equity securities and ETFs executed
   on the NYSE Group's exchanges.

4  Data included in previously identified categories.

5  Data includes currency products.

6  Includes all trading activities for Bclear, NYSE Liffe's clearing service for
   wholesale derivatives.

7  Includes trading in U.S. equity options contracts, not equity-index options.

   Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as
   reported for equity securities.

   All trading activity is single-counted, except European cash trading which is
   double counted to include both buys and sells.

   US Equities data has been updated for Amex integration for October 2008
   forward.

    Source: NYSE Euronext

Related Categories

Press Releases

Stocks Mentioned

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?